HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short rib polydactyly syndrome type 3 with absence of fibulae (Verma-Naumoff syndrome).

Abstract
Short rib polydactyly syndrome (SRPS) is a group of skeletal dysplasias manifested by short-limb dwarfism, short ribs with thoracic dysplasia and polydactyly. SRPS is an inherited autosomal-recessive disorder with different prenatal sonographic and postnatal clinical, histological and radiologic findings. SRPS type 1 (Saldino-Noonan) and type 3 (Verma-Naumoff) are very similar and frequently get mixed. In this report, we present a case of SRPS with hydrops, thoracic hypoplasia, short limbs and postaxial polydactyly in a 27-week fetus. The visceral findings in the fetus including the central nervous system were normal. The karyotype was 46XY. The prenatal diagnosis was thought to be type 1 because of the absence of fibulae at ultrasonography. However, postmortem autopsy, histologic, and radiologic findings were reviewed and the diagnosis was type 3 SRPS because of absence of visceral anomalies, presence of fan-shaped iliac bones and short tubular bones with metaphyseal widening. We concluded that detailed ultrasonography performed in the prenatal period is very important in the diagnosis and differential diagnosis of SRPS.
AuthorsPinar Kumru, Nurettin Aka, Gültekin Köse, Zeynep Tuzcular Vural, Onder Peker, Hülya Kayserili
JournalFetal diagnosis and therapy (Fetal Diagn Ther) Vol. 20 Issue 5 Pg. 410-4 ( 2005) ISSN: 1015-3837 [Print] Switzerland
PMID16113563 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright (c) 2005 S. Karger AG, Basel.
Topics
  • Abnormalities, Multiple (diagnostic imaging)
  • Adult
  • Diagnosis, Differential
  • Female
  • Fibula (abnormalities)
  • Humans
  • Pregnancy
  • Short Rib-Polydactyly Syndrome (diagnostic imaging)
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: